Back to search

Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes

Data up to Jan 2025

Published2001
Citations33
References26

Total Citations Per Year

Abstract

References (26)

Incidence of Adverse Drug Reactions in Hospitalized Patients

1998 • 4,749 citations

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

1994 • 2,716 citations

Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

1999 • 722 citations

Tardive Dyskinesia

1982 • 660 citations

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

1996 • 473 citations

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1997 • 242 citations

Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders

1992 • 241 citations

D3 dopamine receptor mRNA is widely expressed in the human brain

1998 • 237 citations

Proposed Schizophrenia-Related Gene Polymorphism: Expression of the Ser9Gly Mutant Human Dopamine D3Receptor with the Semliki Forest Virus System

1996 • 233 citations

The relationship between paroxetine and the sparteine oxidation polymorphism

1992 • 204 citations

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia

2000 • 169 citations

Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia

1999 • 163 citations

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1999 • 153 citations

Dopamine Receptor Transcript Expression in Striatum and Prefrontal and Occipital Cortex

1997 • 142 citations

Polymorphic Drug Oxidation

1996 • 141 citations

Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment

1989 • 118 citations

Effects of smoking on fluphenazine clearance in psychiatric inpatients

1985 • 117 citations

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

2000 • 94 citations

Biotransformation enzyme polymorphism and pesticide susceptibility.

2000 • 66 citations

Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain

1995 • 64 citations

Cigarette smoking and chlorpromazine disposition and actions

1982 • 46 citations

Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.

1983 • 41 citations

Possible genetic factors underlying the pathophysiology of tardive dyskinesia

1994 • 33 citations

Search for a Susceptibility Locus to Tardive Dyskinesia

1997 • 30 citations

The emerging field of ecogenetics.

2000 • 29 citations

Search for a Susceptibility Locus to Tardive Dyskinesia

1997 • 27 citations

Cited By (0)

Loading...